The Native Antigen Company is part of LGC Clinical Diagnostics - Learn More

0 Items
Select Page

Mouse Anti-Human Immunodeficiency Virus (HIV-1) Integrase (2E3)

$484.76 excl. VAT

Mouse anti Human Immunodeficiency Virus Integrase (2E3) is specific for HIV-1, epitope 1-16 aa. No cross-reaction with TrpE protein and HIV-2 Integrase. Suitable for use in ELISA and Western blot.

MOUSE ANTI-HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) INTEGRASE (2E3)

Mouse anti HIV-1 Integrase (2E3) antibody has been developed for use in ELISA and Western blot.

 

PRODUCT DETAILS – MOUSE ANTI-HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) INTEGRASE (2E3)

  • Mouse anti HIV-1 Integrase (Clone 2E3). Mouse IgG1 with a κ light chain.
  • Specific for HIV-I integrase protein, epitope 1-16 aa. No cross-reaction with TrpE protein and HIV-2 Integrase.
  • Purified from supernatants of hybridoma cell cultures by affinity chromatography.
  • Presented in 100mM sodium citrate, 50mM Tris and 0.05% v/v glycerol. Neutral pH.
  • For use in Western blotting and ELISA.

 

BACKGROUND

Human immunodeficiency virus (HIV) is a retrovirus (genus Lentivirus) with a single-stranded, positive-sense RNA genome. Upon entry of the target cell, the viral RNA genome is converted to double-stranded DNA by a virally encoded reverse transcriptase that is present in the virus particle. This viral DNA is then integrated into the cellular DNA by a virally encoded integrase allowing the genome to be transcribed. Once the virus has infected the cell, two pathways are possible: either the virus becomes latent and the infected cell continues to function, or the virus becomes active and replicates, and a large number of virus particles are liberated to infect other cells. Infection with HIV leads to a condition in which the immune system begins to fail, leading to opportunistic infections.

Integration of viral DNA into a chromosome of the host cell is an essential step in the retroviral life cycle. This process is catalyzed by the viral enzyme integrase (IN) through 3 steps: first step, two nucleotides are removed from the 39 ends of the viral DNA (39-end processing); second step, the recessed 39 ends of the viral DNA are then joined to 59 staggered sites in the target DNA in a concerted cleavage and ligation reaction (DNA joining); last step, integration is completed by repair of the short gaps flanking the viral DNA intermediate and subsequent joining of the 59 ends of viral DNA to the target DNA.

 

REFERENCES

  • Chiu and Davies (2004). Structure and function of HIV-1 integrase. Curr Top Med Chem. 4(9):965-77.

Product datasheet
Safety datasheet

Ambient